BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Business

  Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Treatment, Receives Special Approval for Emergency in Japan

  Merck and Ridgeback Biotherapeutic today announced that Japan’s Ministry of Health, Labor and Welfare has granted Special Approval for Emergency in Japan for molnupiravir, an investigational oral antiviral medicine, for infectious disease caused by SARS-CoV-2.

  December 24, 2021

   · 

  19 min read
• Deals

  Amador Bioscience completed the acquisition of Ann Arbor Pharmacometrics Group (A2PG)

  Amador Bioscience announced today that it has completed the acquisition of Ann Arbor Pharmacometrics Group ( A2PG), a premier pharmacometrics consulting firm based in Ann Arbor, Michigan.

  December 24, 2021

   · 

  3 min read
• BioMidwest

  Rhaeos, Inc. Raises $2.2 Million in Oversubscribed Seed Round

  Rhaeos, Inc. today announced the successful closing of its oversubscribed $2.2 million seed financing.

  December 24, 2021

   · 

  3 min read